Billions in opioid settlement money was meant to be spent on treating and preventing addiction — but what happens if it's ...

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more ...

While a wave of books and Netflix docudramas has promoted an oversimplified and often misleading storyline, new data from the ...

International Day against Drug Abuse & Illicit Trafficking was observed across the state on Thursday under the common team, ...

However, misuse and abuse of opioids in the U.S. is a serious societal concern, which is why the development of abuse-deterrent formulations of these medicines is a high priority,” said Bob ...

PALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release ...

Palm Beach, FL – June 18, 2025 – The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opioids with abuse-deterrent formulations could ...

PALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release ...

RoxyBond, a Schedule II full opioid agonist, utilizes proprietary abuse-deterrent technology to prevent misuse and abuse.

Our work has focused on understanding factors contributing to the opioid crisis and how these factors, whether intentionally or unintentionally, have caused the crisis to evolve. While we agree that ...

The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc's opioid painkiller Roxicodone, saying some parts of the company's application need ...